US Stock MarketDetailed Quotes
UTHR United Therapeutics
- 238.260
- +4.410+1.89%
Close Apr 29 16:00 ET
- 238.260
- 0.0000.00%
Post 16:00 ET
11.21BMarket Cap12.03P/E (TTM)
240.930High234.760Low496.60KVolume234.760Open233.850Pre Close118.44MTurnover1.15%Turnover Ratio12.03P/E (Static)47.06MShares261.54052wk High1.87P/B10.33BFloat Cap204.44052wk Low--Dividend TTM43.37MShs Float283.090Historical High--Div YieldTTM2.64%Amplitude4.275Historical Low238.500Avg Price1Lot Size
United Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 21.87%978M | 17.55%150.7M | 33.87%346.2M | -16.30%106.3M | 29.82%374.8M | 34.15%802.5M | -26.58%128.2M | 39.33%258.6M | -14.30%127M | 221.49%288.7M |
| Net income from continuing operations | 35.40%984.8M | 64.35%217.1M | 11.83%267.6M | 123.45%259.2M | 0.42%240.9M | 52.86%727.3M | 17.74%132.1M | 47.08%239.3M | -32.79%116M | 747.70%239.9M |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | 92.33%-7.1M | -785.71%-6.2M | ---- | ---- | ---- |
| Depreciation and amortization | 3.70%53.2M | 3.79%13.7M | 3.10%13.3M | 1.57%12.9M | 6.40%13.3M | 2.81%51.3M | 4.76%13.2M | 4.03%12.9M | 2.42%12.7M | 0.00%12.5M |
| Other non cash items | -109.33%-4.9M | -163.29%-5M | -118.00%-1.8M | -108.33%-3.9M | 147.54%5.8M | -20.33%52.5M | -79.16%7.9M | -67.74%10M | 750.91%46.8M | -43.53%-12.2M |
| Change In working capital | 30.74%-97.8M | -4.44%-91.7M | 730.14%46M | -57.28%-179.3M | 87.33%127.2M | 18.94%-141.2M | -165.26%-87.8M | 84.23%-7.3M | -54.68%-114M | 421.80%67.9M |
| -Change in receivables | -169.59%-58.5M | -279.65%-20.3M | 124.01%14M | -4,832.14%-138.1M | 205.69%85.9M | 47.46%-21.7M | -19.86%11.3M | -48.35%-58.3M | 91.36%-2.8M | 72.39%28.1M |
| -Change in inventory | -1.49%-13.6M | 49.64%-7M | -416.67%-3.1M | 78.26%-1M | -143.86%-2.5M | -78.67%-13.4M | -13,800.00%-13.9M | 92.68%-600K | -253.33%-4.6M | 359.09%5.7M |
| -Change in payables and accrued expense | 28.31%57.1M | -353.85%-23.1M | 76.68%39.4M | 59.00%38M | 125.93%2.8M | 456.00%44.5M | 126.38%9.1M | 12.63%22.3M | -12.13%23.9M | 56.80%-10.8M |
| -Change in other working capital | 45.02%-82.8M | 56.20%-41.3M | -114.68%-4.3M | 40.08%-78.2M | -8.69%41M | -33.39%-150.6M | -648.41%-94.3M | 257.53%29.3M | -82.52%-130.5M | 540.20%44.9M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 21.87%978M | 17.55%150.7M | 33.87%346.2M | -16.30%106.3M | 29.82%374.8M | 34.15%802.5M | -26.58%128.2M | 39.33%258.6M | -14.30%127M | 221.49%288.7M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 11.32%-719.6M | 122.24%42.1M | -233.40%-313.4M | -34.44%-227.2M | 38.45%-221.1M | -66.67%-811.5M | 3.32%-189.3M | 60.15%-94M | -245.60%-169M | -5,601.59%-359.2M |
| Net PPE purchase and sale | -65.99%-230.4M | -99.24%-78.7M | 4.51%-65.7M | -162.94%-44.7M | -205.93%-41.3M | -14.90%-138.8M | 44.05%-39.5M | -195.28%-68.8M | -4.29%-17M | -27.36%-13.5M |
| Net business purchase and sale | ---89.2M | -6,046.67%-89.2M | ---- | ---- | ---- | --0 | --1.5M | ---- | ---- | ---- |
| Net investment purchase and sale | 44.25%-377M | 241.28%218.7M | -900.42%-237.1M | -17.63%-178.8M | 47.99%-179.8M | -84.70%-676.2M | -23.64%-154.8M | 89.25%-23.7M | -512.90%-152M | -8,139.53%-345.7M |
| Net other investing changes | -757.14%-23M | ---8.7M | ---10.6M | ---- | ---- | --3.5M | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 11.32%-719.6M | 122.24%42.1M | -233.40%-313.4M | -34.44%-227.2M | 38.45%-221.1M | -66.67%-811.5M | 3.32%-189.3M | 60.15%-94M | -245.60%-169M | -5,601.59%-359.2M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -115.78%-11.9M | -267.21%-92.8M | 8.57%7.6M | 3.35%24.7M | 541.82%48.6M | 68.30%75.4M | 640.00%55.5M | -57.83%7M | 125.47%23.9M | -208.91%-11M |
| Net issuance payments of debt | ---100M | ---100M | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Net common stock issuance | -21.05%-13.8M | ---100K | 33.33%-200K | --0 | -21.62%-13.5M | -5.56%-11.4M | --0 | -50.00%-300K | --0 | -8.82%-11.1M |
| Proceeds from stock option exercised by employees | 10.92%104.6M | -86.85%7.3M | 6.85%7.8M | 3.35%24.7M | 752.63%64.8M | 69.60%94.3M | 620.78%55.5M | -56.55%7.3M | 121.30%23.9M | -62.56%7.6M |
| Net other financing activities | 64.00%-2.7M | --0 | --0 | --0 | 64.00%-2.7M | ---7.5M | --0 | --0 | --0 | ---7.5M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -115.78%-11.9M | -267.21%-92.8M | 8.57%7.6M | 3.35%24.7M | 541.82%48.6M | 68.30%75.4M | 640.00%55.5M | -57.83%7M | 125.47%23.9M | -208.91%-11M |
| Net cash flow | ||||||||||
| Beginning cash position | 7.42%961.2M | 14.57%1.11B | 34.22%1.07B | 43.06%1.16B | 7.42%961.2M | 21.13%894.8M | 6.42%966.8M | -15.60%795.2M | -2.28%813.3M | 21.13%894.8M |
| Current changes in cash | 271.23%246.5M | 1,885.71%100M | -76.46%40.4M | -431.49%-96.2M | 348.22%202.3M | -57.46%66.4M | 59.12%-5.6M | 609.20%171.6M | -116.47%-18.1M | -187.07%-81.5M |
| End cash Position | 25.65%1.21B | 25.65%1.21B | 14.57%1.11B | 34.22%1.07B | 43.06%1.16B | 7.42%961.2M | 7.42%961.2M | 6.42%966.8M | -15.60%795.2M | -2.28%813.3M |
| Free cash flow | 12.64%747.6M | -18.83%72M | 47.79%280.5M | -44.00%61.6M | 21.18%333.5M | 39.02%663.7M | -14.71%88.7M | 16.94%189.8M | -16.60%110M | 247.47%275.2M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg